Abstract:In silico modeling of blood-brain barrier (BBB) permeability plays an important role in early discovery of central nervous system (CNS) drugs due to its high-throughput and cost-effectiveness. Natural products (NP) have demonstrated considerable therapeutic efficacy against several CNS diseases. However, BBB permeation property of NP is scarcely evaluated both experimentally and computationally. It is well accepted that significant difference in chemical spaces exists between NP and synthetic drugs, which calls into doubt on suitability of available synthetic chemical based BBB permeability models for the evaluation of NP. Herein poor discriminative performance on BBB permeability of NP are first confirmed using internal constructed and previously published drug-derived computational models, which warrants the need for NP-oriented modeling. Then a quantitative structure property relationship (QSPR) study on a NP dataset was carried out using four different machine learning methods including support vector machine, random forest, Naive Bayes and probabilistic neural network with 67 selected features. The final consensus model was obtained with approximate 90% overall accuracy for the cross-validation study, which is further taken to predict passive BBB permeability of a large dataset consisting of over 10,000 compounds from traditional Chinese medicine (TCM). For 32 selected TCM molecules, their predicted BBB permeability were evaluated by in vitro parallel artificial membrane permeability assay and overall accuracy for in vitro experimental validation is around 81%. Interestingly, our in silico model successfully predicted different BBB permeation potentials of parent molecules and their known in vivo metabolites. Finally, we found that the lipophilicity, the number of hydrogen bonds and molecular polarity were important molecular determinants for BBB permeability of NP. Our results suggest that the consensus model proposed in current work is a reliable tool for prioritizing potential CNS active NP across the BBB, which would accelerate their development and provide more understanding on their mechanisms, especially those with pharmacologically active metabolites. (C) 2017 Elsevier Inc. All rights reserved.

A hybrid evaluation of the intestinal absorption performance of compounds from molecular structure

Absorption Barriers in the Rat Intestinal Mucosa: 2. Application of Physiologically Based Mathematical Models to Quantify Mechanisms of Drug Permeation and Metabolism

Predicting Human Intestinal Absorption from Three Dimensional Molecular Structure of Drugs

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

New Understanding from Intestinal Absorption Model: How Physiological Features Influence Mass Transfer and Absorption

ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.

Development of Ussing Model Coupled with Artificial Membrane for Predicting Intestinal Absorption Mechanisms of Drugs

Advances in models for predicting drug intestinal permeability

ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting

QSPR Study on the Permeability of Drugs Across Caco-2 Monolayer

Qsar Study and Volsurf Characterization of Human Intestinal Absorption of Drugs

Assessing the Intestinal Permeability of Small Molecule Drugs Via Diffusion Motion on a Multidimensional Free Energy Surface.

Evaluation of Intestinal Drug Absorption and Interaction Using Quadruple Single-Pass Intestinal Perfusion Coupled with Mass Spectrometry Imaging

Intestinal Absorption Models on the Basis of the Theory of Mass Transfer in the Fluid Systems

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.

Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption

Prediction of Human Absorption of Natural Compounds by the Non-Everted Rat Intestinal Sac Model

Current Status of Mechanism-Based Gastrointestinal Absorption Modeling Following Oral Administration

Study on the compatibility interactions of formula Ding-Zhi-Xiao-Wan based on their main components transport characteristics across Caco-2 monolayers model

Mathematical Modeling of the Gastrointestinal System for Preliminary Drug Absorption Assessment